|
Volumn 33, Issue 11-12, 2012, Pages 370-373
|
Multiple endocrine neoplasia, the old and the new: a mini review.
|
Author keywords
[No Author keywords available]
|
Indexed keywords
BIOLOGICAL MARKER;
CYCLIN DEPENDENT KINASE INHIBITOR 1B;
PROTEIN KINASE INHIBITOR;
ADRENAL TUMOR;
ALLELE;
ANIMAL;
BLOOD;
DISEASE COURSE;
EXON;
GENETIC POLYMORPHISM;
GENETICS;
GENOTYPE;
HUMAN;
HYPERPARATHYROIDISM;
METABOLISM;
MISSENSE MUTATION;
MULTIPLE ENDOCRINE NEOPLASIA;
NEUROFIBROMATOSIS;
PHENOTYPE;
PHEOCHROMOCYTOMA;
REVIEW;
RISK ASSESSMENT;
RISK FACTOR;
SIPPLE SYNDROME;
SYNDROME;
THYROID TUMOR;
THYROIDECTOMY;
TREATMENT OUTCOME;
ADRENAL GLAND NEOPLASMS;
ALLELES;
ANIMALS;
BIOLOGICAL MARKERS;
CYCLIN-DEPENDENT KINASE INHIBITOR P27;
DISEASE PROGRESSION;
EXONS;
GENOTYPE;
HUMANS;
HYPERPARATHYROIDISM;
MULTIPLE ENDOCRINE NEOPLASIA;
MULTIPLE ENDOCRINE NEOPLASIA TYPE 1;
MULTIPLE ENDOCRINE NEOPLASIA TYPE 2A;
MULTIPLE ENDOCRINE NEOPLASIA TYPE 2B;
MUTATION, MISSENSE;
PHENOTYPE;
PHEOCHROMOCYTOMA;
POLYMORPHISM, GENETIC;
PROTEIN KINASE INHIBITORS;
RISK ASSESSMENT;
RISK FACTORS;
SYNDROME;
THYROID NEOPLASMS;
THYROIDECTOMY;
TREATMENT OUTCOME;
|
EID: 84875805070
PISSN: 03919005
EISSN: None
Source Type: Journal
DOI: None Document Type: Review |
Times cited : (12)
|
References (0)
|